SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Aug 15 3:35 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NeuroInvestment who wrote (930)12/12/1997 12:34:00 PM
From: (no name provided)  Read Replies (2) of 1359
 
Neuroinvestment,

Your logic is slightly flawed. If you read the WSJ article, then you would realize that this was NOT a echocardiographic study of a large group of Redux/Pondimin users. These were merely initial case reports of valvular pathology in diet pill users.

Of course, they are short 3,299,970. But by the same logic as you use above, there would be no AIDS epidemic. The first case reports were less than 10 gay men with immune deficiency. Just as those cases were the tip of the iceberg, the Belgian cases were probably just the first.

Look, IPIC has some great potential in the other projects, but they fell into a quagmire. This is no longer investment-grade stock. You are a smart guy from what I tell of your postings. But you are defending a sunken ship. Cut your losses and retain your credibility.

Kafka666
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News